2017-11-15T16:33:36-06:00 2017-03-31 KPMG LLP 345 Park Avenue New York NY 101540102 990 2016-04-01 131949477 New York Blood Center Inc % C ELIZABETH GIBSON NEWY 2125703100 310 East 67th Street New York NY 10065 C ELIZABETH GIBSON SR. VP & CFO 2125703016 2017-11-14 true PHILLIP GROFF P01247783 2127589700 2017-11-14 167.68.102.5 13407320173195000118 2017-11-15 P 906143BF9E00D34D78FD7AF47A8DEC67B850B94D 906143BF9E00D34D78FD7AF47A8DEC67B850B94D 2016 2017-02-10 21:41:12Z Dr Christopher Hillyer 310 East 67th Street New York NY 10065 422319107 false X nybloodcenter.org X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. 17 15 1323 200 108897 14044399 12829969 312108036 319980728 7990517 13680873 749098 446531 334892050 346938101 114355 6125539 0 0 112675762 116244375 73512 0 236342 223162561 248738879 336026190 371108793 -1134140 -24170692 469404674 515751776 67650304 79945233 401754370 435806543 X AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. false false 160508785 125539 169158061 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS, AND THE DISTRIBUTION OF THESE PRODUCTS TO HOSPITALS IN THE GREATER NY AREA FOR TRANSFUSIONS TO PATIENTS. 155928493 150822667 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES (INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM; AND (3) HEMOPHILIA SERVICES CONSORTIUM. NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING AND STORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITS FOR TREATMENT OR FOR RESEARCH PURPOSES. 20682491 6000000 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES A WIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD AND BLOOD RELATED DISEASES. 337119769 true true false true false false false false false false true true true false true true false true false false true false false false false false false true true true false false false false false false true false true false false false false true true true false false true 143 0 true 1323 true true true false false false false false false false false false X 17 15 true false false false false false false true true false false true true true true true true true true false CT NJ NY OK X C ELIZABETH GIBSON 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 Andrew Bodnar TRUSTEE 5.0 0.0 X 0 0 0 HARRIET EDELMAN TRUSTEE 2.0 0.0 X 0 0 0 PHILIP FALIVENE TRUSTEE 1.0 0.0 X 0 0 0 THOMAS HEANEY TRUSTEE (BEG 8/1/2016) 1.0 0.0 X 0 0 0 MICHAEL HODIN TRUSTEE 2.0 0.0 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.0 2.0 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 2.0 0.0 X 0 0 0 MARC KRAMER TRUSTEE 1.0 0.0 X 0 0 0 DAVID TENDLER VICE CHAIR, BOARD OF TRUSTEES 5.0 2.0 X X 0 0 0 MICHELLE MIAO TRUSTEE 1.0 0.0 X 0 0 0 HOWARD MILSTEIN CHAIRMAN, BOARD OF TRUSTEES 7.5 2.0 X X 0 0 0 STEPHEN D WURTZLER TRUSTEE 1.0 1.0 X 0 0 0 PAUL M TORGERSON TRUSTEE (BEG 8/1/2016) 1.0 0.0 X 0 0 0 JENNIFER JONES-AUSTIN TRUSTEE 1.0 0.0 X 0 0 0 AARON R MARCU TRUSTEE 2.0 0.0 X 0 0 0 JOHN MULLEN TRUSTEE 2.0 0.0 X 0 0 0 Owen Garrick Trustee (until 10/19/2016) 1.0 0.0 X 0 0 0 CHRISTOPHER HILLYER MD PRESIDENT & CEO 50.0 4.0 X X 1568412 0 97141 C ELIZABETH GIBSON SVP, CHIEF FINANCIAL OFFICER 50.0 0.0 X 431391 0 50484 BETH SHAZ MD SVP, CHIEF MEDICAL officer 50.0 3.0 X 553232 0 65487 ELIZABETH MCQUAIL SVP, CHIEF OPERATING OFFICER 50.0 2.0 X 497191 0 75802 BETSY JETT VP, QUALITY AND REGULATORY AFF 50.0 0.0 X 380287 0 44057 JORDANA G SCHWARTZ VP, GENERAL COUNSEL & SECr 50.0 2.0 X 395489 0 55957 BERNADETTE TISO ASSISTANT SECRETARY 50.0 1.0 X 223314 0 45420 DORIANE GLORIA SVP - CHIEF ADMINISTRATIVE OFF 50.0 0.0 X 334139 0 44089 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFF 50.0 0.0 X 311723 0 53021 PABLO RUBINSTEIN VP - NCBP 50.0 0.0 X 374940 0 47977 MOHANDAS NARLA VP - LFRKI 50.0 0.0 X 367730 0 46631 ROBERT PURVIS VP - CUSTOMER SERVICE 50.0 0.0 X 340135 0 50191 CONNIE WESTHOFF DIR - IMMUNOHEMATOLOGY 50.0 0.0 X 308124 0 37690 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 50.0 0.0 X 299069 0 46609 6385176 0 760556 126 false true false CREATIVE TESTING SOLUTIONS PO BOX 29871 PHOENIX AZ 85038 BLOOD TESTING 16721740 ATOS IT SOLUTIONS PO BOX 710878 COLUMBUS OH 43271 IT OUTSOURCE 2595515 DMI GC HOLDING 13700 OAKLAND AVE HIGHLAND PARK MI 48203 TELEMARKETING 1755914 ALL SYSTEMS MESSENGER 3391 MERRICK ROAD WANTAGH NY 11793 DELIVERY 1408501 MAK SYSTEMS 2720 RIVER ROAD DES PLAINES IL 60018 SOFTWARE 1381808 5 9496449 3333520 131627 12829969 BLOOD SERVICES 621500 169158061 169158061 MEDICAL PROGRAMS 621500 150822667 150822667 319980728 8119718 108897 8010821 0 0 446531 446531 0 446531 446531 80041112 901049 74549742 831264 5491370 69785 5561155 5561155 0 0 0 0 0 0 0 0 0 0 346938101 319980728 108897 14018507 6005884 6005884 119655 119655 0 0 0 5794506 5794506 36539 36539 80929968 74874228 5917068 138672 5099357 4589421 509936 17406361 15837575 1565409 3377 6977644 6349252 621394 6998 226615 9375 217240 2419228 2419228 429883 429883 192212 192212 0 1261520 1261520 2420295 1225441 1117159 77695 100269 100269 417182 375241 41941 3316804 3316804 22042 22042 4046761 3971039 75722 275074 206918 68156 0 44932 43660 1272 1017940 1017940 0 10813388 7617665 3195723 1821190 1634813 186377 SUPPLIES 156412481 156204182 208299 OTHER EXPENSES 23794863 18081720 5703543 9600 TESTING FEES 17506655 17506655 MGMT FEE-HEMOPHILIA CONSORTIUM 11660870 11660870 10538675 9437173 1101502 371108793 337119769 33752682 236342 4455192 4707007 33284234 24591117 0 0 40878699 43548481 0 0 0 0 0 0 50234156 40899722 2860998 2900306 184295220 134831691 53842520 49463529 221770456 242684198 42379995 48801856 18349883 57706046 1348541 449514 0 0 469404674 515751776 38129620 54032947 0 0 5370758 7759054 0 0 0 0 0 0 19361333 14638522 0 0 4788593 3514710 67650304 79945233 X 401331946 434991789 422424 814754 0 0 401754370 435806543 469404674 515751776 X -24170692 17592818 40630047 X false true X true true true X 8973000 10720155 10435452 14044399 12829969 57002975 300205000 298860345 298464704 312108036 319980728 1529618813 0 0 0 309178000 309580500 308900156 326152435 332810697 1586621788 214413 85000 136261 490440 777863 1703977 0 214413 85000 136261 490440 777863 1703977 1584917811 20112000 9488429 9665929 8777204 8457352 56500914 0 20112000 9488429 9665929 8777204 8457352 56500914 0 0 329290000 319068929 318566085 334929639 341268049 1643122702 0.96458 0.96117 0.03439 0.03810 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 192212 192212 370916581 371108793 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 76966 73117 138869 192212 481164 250000 250000 250000 250000 1000000 1500000 2118174 2118174 35060594 34992198 68396 44622575 13608077 31014498 55486027 47017052 8468975 47007850 39214364 7793486 49463529 PRIVATE INVESTMENT FUNDS 19634229 F HEDGE FUNDS 29167627 F 48801856 INTEREST IN CBC 20904784 F INTEREST IN IBR 36801262 F 57706046 0 RESERVE FOR CLAIMS 1000000 FMV OF INTEREST RATE SWAP AGRE 2514710 3514710 X UNCERTAIN TAX POSITIONS SCHEDULE D, PART X, LINE 2 THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NOT-FOR-PROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NOT-FOR-PROFIT CORPORATION, NYBC IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THE ORGANIZATION DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED MARCH 31, 2017 AND 2016. Sub-Saharan Africa Program Services ROYALTIES 3600000 Central America and the Caribbean Investments 1348104 Central America and the Caribbean Investments 4515778 9463882 9463882 true false true true true false true HUMANE SOCIETY OF THE US 1255 23RD ST NW WASHINGTON DC 20037 530225390 501(c)(3) 6000000 CHIMPANZEE SANCTUARY 1 COLLEGE SCHOLARSHIPS 187 119655 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATIONS LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III, LINE 1 COLLEGE SCHOLARSHIPS AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X false true false false false false false true false CHRISTOPHER HILLYER MD PRESIDENT & CEO 944412 0 600000 0 24000 0 66500 0 30641 0 1665553 0 0 0 C ELIZABETH GIBSON SVP, CHIEF FINANCIAL OFFICER 373611 0 39780 0 18000 0 27846 0 22638 0 481875 0 0 0 BETH SHAZ MD SVP, CHIEF MEDICAL officer 498494 0 36738 0 18000 0 35000 0 30487 0 618719 0 0 0 ELIZABETH MCQUAIL SVP, CHIEF OPERATING OFFICER 424555 0 54636 0 18000 0 45161 0 30641 0 572993 0 0 0 BETSY JETT VP, QUALITY AND REGULATORY AFF 345287 0 35000 0 0 0 24500 0 19557 0 424344 0 0 0 JORDANA G SCHWARTZ VP, GENERAL COUNSEL & SECr 358718 0 36771 0 0 0 25740 0 30217 0 451446 0 0 0 PABLO RUBINSTEIN VP - NCBP 374940 0 0 0 0 0 37500 0 10477 0 422917 0 0 0 MOHANDAS NARLA VP - LFRKI 367730 0 0 0 0 0 25992 0 20639 0 414361 0 0 0 ROBERT PURVIS VP - CUSTOMER SERVICE 318985 0 3150 0 18000 0 22050 0 28141 0 390326 0 0 0 DORIANE GLORIA SVP - CHIEF ADMINISTRATIVE OFF 281379 0 34760 0 18000 0 20542 0 23547 0 378228 0 0 0 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFF 277023 0 29500 0 5200 0 20650 0 32371 0 364744 0 0 0 CONNIE WESTHOFF DIR - IMMUNOHEMATOLOGY 293495 0 14629 0 0 0 18550 0 19140 0 345814 0 0 0 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 290219 8850 18550 28059 345678 BERNADETTE TISO ASSISTANT SECRETARY 212440 0 10874 0 0 0 16217 0 29203 0 268734 0 0 0 SCHEDULE J, PART I, LINE 4B THE INDIVIDUALS LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. NO PAYMENTS WERE RECEIVED IN 2016 and no amounts includable in income as they were not vested and are subject to a substantial risk of forfeiture. - CHRISTOPHER HILLYER - ELIZABETH MCQUAIL - C. ELIZABETH GIBSON - BETH SHAZ - MOHANDAS NARLA - DORIANE GLORIA - jORDANA SCHWARTZ - PABLO RUBINSTEIN - BETSY JETT - MICHELE SCAGGIANTE - ROBERT PURVIS SCHEDULE J, PART I, LINE 7 Upon the organization achieving certain budget thresholds, executives other than the CEO were eligible for merit bonuses of up to 5% or 10% of their annual base salaries, determined by their achieving performance benchmarks established by senior management and approved by the Compensation Committee of the Board. Julie Bonilla TRUSTEE FAMILY MEMBER 36539 EMPLOYEE COMPENSATION false X 1 3082 FMV X 3 24033 FMV X TICKETS 5 67840 Estimated Value X misc-other 11 36672 FMV false true false SCHEDULE M, PART 1 DONATIONS ARE REPORTED BASED ON THE NUMBER OF CONTRIBUTIONS RECEIVED IN PART I, COLUMN(B). MISSION STATEMENT PART I, LINE 1 AND PART III, LINE 1 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION. SPECIFICALLY, NYBC EXISTS: -TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS PRIMARILY IN THE GREATER NEW YORK METROPOLITAN AREA -TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH -TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT -TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS GOVERNING BODY PART VI, SECTION A, LINE 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE BUSINESS RELATIONSHIP PART VI, SECTION A, LINE 2 Harriet Edelman, Christopher Hillyer, Michael Hodin, Elizabeth McQuail, Howard Milstein, Mark Schmidtlien, Jordana Schwartz, Beth Shaz, David Tendler, Bernadette Tiso, Stephen Wurtzler: BUSINESS RELATIONSHIP PROCESS OF FORM 990 REVIEW BY GOVERNING BODY PART VI, LINE 11A FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS FINALIZED BY MANAGEMENT, REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM, AND REVIEWED AND APPROVED BY THE AUDIT COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW AND APPROVAL AT ITS ANNUAL MEETING. COMPLIANCE WITH CONFLICT OF INTEREST POLICY PART VI, LINE 12C AT THE BEGINNING OF EACH NEW FISCAL YEAR, AND ON AN AS-NEEDED BASIS, THE TAXPAYER REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS AND, IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE TAXPAYER MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. PROCESSES FOR DETERMINING COMPENSATION PART VI, LINE 15 THE TAXPAYER'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE TAXPAYER USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. PUBLIC AVAILABILITY OF INFORMATION PART VI, LINE 19 THE TAXPAYER MAKES ITS FINANCIAL STATEMENTS AVAILABLE UPON REQUEST, AND ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE BOTH UPON REQUEST AND ON ITS WEBSITE. OTHER CHANGES IN NET ASSETS PART XI, LINE 9 UREALIZED GAIN ON SWAP AGREEMENT 1,273,883 INHERENT CONTRIBUTION - IBR 36,303,919 CHANGE IN INVESTMENT IN AFFILIATES 3,052,245 TOTAL 40,630,047 COMMUNITY BLOOD CENTER OF GREATER KANSAS CITY ACQUISITION ON AUGUST 1, 2014, NYBC BECAME THE SOLE MEMBER OF COMMUNITY BLOOD CENTER OF KANSAS CITY (CBC), A SECTION 501(C)(3) EXEMPT ORGANIZATION WHOSE EXEMPT PURPOSE IS TO COLLECT, PROCESS, TEST, STORE, AND DISTRIBUTE HUMAN BLOOD IN THE GREATER KANSAS CITY, MO AREA. NO CASH CONSIDERATION WAS EXCHANGED AT THE CLOSING OF THE ACQUISITION OF CBC BUT NYBC HAS RECOGNIZED ITS INTEREST IN CBC BY APPLYING THE ACQUISITION METHOD OF ACCOUNTING. Innovative Blood Resources acquisition on August 1, 2016, NYBC became the sole member of Innovative Blood Resources (IBR), a section 501( c)(3) exempt organization whose exempt purpose is to collect, process, test and distribute human blood in St. Paul, Duluth, Minnesota, and Lincoln, Nebraska. No cash consideration was exchanged at the closing of the acquisition of IBR but NYBC has recognized its interest in IBR by applying the acquisition method of accounting. COMMUNITY BLOOD CENTER OF GREATER KANSAS 4040 MAIN STREET KANSAS CITY MO 64111 440616999 BLOOD CENTER MO 501 (C) (3) 10 NY BLOOD CTR true INNOVATIVE BLOOD RESOURCES 737 PELHAM BLVD ST PAUL MN 55114 410693869 BLOOD CENTER MN 501 (C) (3) 10 NY BLOOD CTR true false false false false false false true true false false false true false false true false false false false COMMUNITY BLOOD CENTER OF GREATER KANSAS g 992742 FMV CASH PAID COMMUNITY BLOOD CENTER OF GREATER KANSAS h 10800055 FMV CASH PAID COMMUNITY BLOOD CENTER OF GREATER KANSAS l 934100 FMV CASH PAID COMMUNITY BLOOD CENTER OF GREATER KANSAS o 184764 FMV CASH PAID INNOVATIVE BLOOD RESOURCES g 106353 FMV CASH PAID INNOVATIVE BLOOD RESOURCES h 2768866 FMV CASH PAID